Clinical relevance of inflammation on rectal biopsy for Hirschsprung disease: An outcomes analysis

Abstract

AbstractObjectivesInflammation on diagnostic rectal biopsy for children with suspected Hirschsprung disease (HSCR) is reported on pathology, and its significance is unknown. We describe the management and outcomes of a cohort with inflammation on rectal biopsy compared to those without. Specifically, to address the hypothesis that inflammation on diagnostic biopsy is associated with increased complication rates irrespective of intervention type and timing.MethodsA single institution retrospective review of children with HSCR who underwent biopsy and endorectal pull‐through (ERPT) from 2010 to 2020 was performed. The primary outcome was overall complications at 30‐days following ERPT. Secondary outcomes included timing and type of operative intervention as well as postoperative enterocolitis diagnosed within 6‐months of ERPT.ResultsForty‐nine children were identified; inflammation was present on diagnostic biopsy for 17 children. Those with inflammation were more likely to have clinical evidence of enterocolitis at the time of biopsy (p = 0.001) and were more likely to undergo leveling colostomy before ERPT (p = 0.01). Children with inflammation had a higher anastomotic leak rate (p = 0.04). Subgroup analysis of patients with inflammation undergoing primary ERPT versus leveling colostomy demonstrated no significant difference in outcomes following definitive ERPT.ConclusionsOur study suggests inflammation on diagnostic rectal biopsy for HSCR is associated with increased anastomotic leak rates. While additional prospective studies are indicated, attention to methods of mitigating inflammation and confirming its resolution before definitive pull‐through may be of benefit for improving clinical outcomes in patients found with inflammation on diagnostic rectal biopsy.